PMID- 34249264 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220424 IS - 2008-3866 (Print) IS - 2008-3874 (Electronic) IS - 2008-3866 (Linking) VI - 24 IP - 5 DP - 2021 May TI - Quercetin protects islet beta-cells from oxidation-induced apoptosis via Sirt3 in T2DM. PG - 629-635 LID - 10.22038/ijbms.2021.52005.11792 [doi] AB - OBJECTIVES: Sirt3 may regulate ROS production and might be involved in beta-cell apoptosis, which plays an important role in the progression of type 2 diabetes mellitus (T2DM). Quercetin is a potent anti-oxidative bioflavonoid, but its effects on T2DM remain to be explored. This study aimed to investigate the effects of quercetin on beta-cell apoptosis and explore its mechanisms. MATERIALS AND METHODS: The effects of quercetin were conducted on db/db mice and INS1 cells. Fasting blood glucose was determined by the colorimetric method, serum insulin was measured by enzyme-linked immunosorbent assay (ELISA). Meanwhile, Sirt3 in INS1 cells was knocked down by plasmid transfection. The antioxidant proteins (SOD2 and CAT), apoptosis proteins (cleaved Caspase-3, Bax, and BCL-2), and Sirt3 protein in pancreases and INS1 cells were determined by western blotting. RESULTS: When INS1 cells and diabetic mice were treated with quercetin, the levels of SOD2, CAT, and Sirt3 proteins were increased, the levels of cleaved Caspase-3 and the ratio of Bax to BCL-2 were decreased at different degrees, along with reduced blood glucose levels and elevated insulin levels in diabetic mice. When Sirt3 was knocked down in INS1 cells, increase of two antioxidants and decrease of cell apoptosis generated by quercetin could not occur. CONCLUSION: Quercetin protected islet beta-cells from oxidation-induced apoptosis via Sirt3 in T2DM, which would be beneficial to develop new strategies for preventing beta-cell failure in T2DM. FAU - Wang, Jian-Yun AU - Wang JY AD - Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China. FAU - Nie, Ya-Xing AU - Nie YX AD - Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China. FAU - Dong, Bing-Zheng AU - Dong BZ AD - Department of Urology, Xuzhou Central Hospital, The Affiliated School of Clinical Medicine of Xuzhou Medical University, Xuzhou 221009, Jiangsu, PR China. FAU - Cai, Zhi-Chen AU - Cai ZC AD - Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China. FAU - Zeng, Xuan-Kai AU - Zeng XK AD - Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China. AD - Xuzhou Jiasheng Pharmaceutical Technology Co., Ltd., Xuzhou 221000, Jiangsu, PR China. FAU - Du, Lei AU - Du L AD - Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China. FAU - Zhu, Xia AU - Zhu X AD - Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China. FAU - Yin, Xiao-Xing AU - Yin XX AD - Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221002, Jiangsu, PR China. LA - eng PT - Journal Article PL - Iran TA - Iran J Basic Med Sci JT - Iranian journal of basic medical sciences JID - 101517966 PMC - PMC8244598 OTO - NOTNLM OT - Apoptosis OT - Oxidative stress OT - Quercetin OT - Sirt3 OT - beta-cell COIS- The authors declare that there are no con fl icts of interest associated with this work. EDAT- 2021/07/13 06:00 MHDA- 2021/07/13 06:01 PMCR- 2021/05/01 CRDT- 2021/07/12 05:51 PHST- 2020/09/16 00:00 [received] PHST- 2021/04/11 00:00 [accepted] PHST- 2021/07/12 05:51 [entrez] PHST- 2021/07/13 06:00 [pubmed] PHST- 2021/07/13 06:01 [medline] PHST- 2021/05/01 00:00 [pmc-release] AID - 10.22038/ijbms.2021.52005.11792 [doi] PST - ppublish SO - Iran J Basic Med Sci. 2021 May;24(5):629-635. doi: 10.22038/ijbms.2021.52005.11792.